Limited-Time Offer: Enjoy 50% Savings! - Ends In 0d 00h 00m 00s Coupon code: 50OFF
Welcome to QA4Exam
Logo

- Trusted Worldwide Questions & Answers

SOCRA CCRP Dumps - Pass Certified Clinical Research Professional Exam in First Attempt 2026

The SOCRA CCRP exam, or Certified Clinical Research Professional exam, is part of the SOCRA CCRP Certification track. It is designed for professionals involved in clinical research who want to validate their knowledge and practical understanding of the field. This certification matters because it reflects competency across key stages of clinical research operations and supports professional credibility. Preparing well for the CCRP exam can help candidates approach the test with greater confidence and focus.

# Exam Topics Sub-Topics Approximate Weightage (%)
1 Research Study Start-Up Protocol review, site initiation, regulatory documentation, study activation 30%
2 Research Study Implementation Subject enrollment, data collection, source documentation, safety reporting 45%
3 Research Study Closure Closeout procedures, record reconciliation, final reporting, document archiving 25%

The SOCRA CCRP exam tests how well candidates understand the clinical research lifecycle, from study start-up through implementation and closure. It evaluates practical knowledge, process awareness, and the ability to apply concepts in real-world research settings. Candidates should be prepared for questions that measure both accuracy and judgment across core operational tasks.

How QA4Exam.com Helps You Pass

QA4Exam.com provides Exam PDF materials with actual questions and answers that help you study with a clear focus on the CCRP exam format. The Online Practice Test gives you a realistic exam simulation so you can build confidence before test day. You also get up-to-date questions and verified answers, which makes your preparation more efficient and reliable. In addition, practicing under timed conditions helps improve time management and reduces exam-day pressure. These resources are designed to support faster review and stronger readiness for the SOCRA CCRP exam.

FAQ

What is the SOCRA CCRP exam?

The SOCRA CCRP exam is the Certified Clinical Research Professional exam offered under the SOCRA CCRP Certification. It is intended for clinical research professionals who want to demonstrate their knowledge and skills in this area.

Who should take the CCRP exam?

The exam is suitable for professionals working in clinical research who want formal recognition of their expertise. It is especially useful for candidates involved in study start-up, implementation, and closure activities.

Is the SOCRA CCRP exam difficult?

The difficulty depends on your experience and preparation level. Candidates who understand the exam topics and practice with realistic questions usually feel more confident on test day.

Can I pass with only braindumps?

Braindumps alone are not the best approach. You should combine them with review and practice so you understand the concepts behind the answers and improve your overall readiness.

Do I need hands-on experience to pass CCRP?

Hands-on experience can help because the exam covers practical clinical research tasks. However, focused study with quality exam materials and practice tests can also strengthen your preparation.

Are QA4Exam.com dumps and practice test enough for first attempt success?

QA4Exam.com resources can be a strong part of your preparation because they include actual questions and answers, up-to-date content, and a practice test format. Using them consistently can improve accuracy, timing, and confidence for a first attempt.

What format do the QA4Exam.com CCRP materials use?

The materials are available as an Exam PDF and an Online Practice Test. This combination lets you study offline, review verified answers, and practice in a simulated exam environment.

The questions for CCRP were last updated on Jun 7, 2026.
  • Viewing page 1 out of 26 pages.
  • Viewing questions 1-5 out of 130 questions
Get All 130 Questions & Answers
Question No. 1

In accordance with 45 CFR 46, in addition to the Office for Human Research Protections (OHRP), a suspension of IRB/IEC approval must be reported to which of the following?

Show Answer Hide Answer
Correct Answer: B

If IRB/IEC approval is suspended or terminated, reporting is required to protect oversight and accountability.

45 CFR 46.113: ''An IRB shall notify the institutional officials, the department or agency head, and OHRP (when applicable) of any suspension or termination of IRB approval.''

This ensures transparency and institutional responsibility for compliance. Internal hospital committees or directors (A, C, D) are not mandated reporting entities.

Thus, the correct answer is B (Appropriate institutional officials).


45 CFR 46.113 (Suspension or termination of IRB approval).

Question No. 2

Which of the following identifies content that should be included in a clinical research protocol?

Show Answer Hide Answer
Correct Answer: D

The protocol must provide scientific rationale, including prior nonclinical findings that justify human research.

ICH E6(R2) 6.2.2: ''The protocol should include... a summary of findings from nonclinical studies that potentially have clinical significance and from clinical trials that are relevant to the trial.''

Other listed options belong elsewhere:

IRB approvals (A) are separate administrative records.

SOPs for data collection (B) are sponsor-level procedural documents.

Investigator selection (C) is a sponsor's responsibility, not protocol content.

Thus, the correct answer is D (Summary of nonclinical findings with clinical relevance).


ICH E6(R2), 6.2.2 (Protocol contents).

Question No. 3

In accordance with the ICH GCP Guideline, who is responsible for the accuracy, completeness, legibility, and timeliness of the data reported to the sponsor in the case report forms and in all required reports?

Show Answer Hide Answer
Correct Answer: A

The investigator holds ultimate responsibility for all data reported.

ICH E6(R2) 4.9.1: ''The investigator is responsible for the accuracy, completeness, legibility, and timeliness of the data reported to the sponsor on the CRFs and all required reports.''

Monitors (D) verify data accuracy but are not responsible for data quality. Quality specialists (B) and IRB staff (C) have no role in data entry.

Correct answer: A (The clinical investigator).


ICH E6(R2), 4.9.1.

Question No. 4

A clinical investigator terminated a Phase IV drug study. In accordance with the ICH GCP Guidelines, which of the following documents should the clinical investigator maintain?

Show Answer Hide Answer
Correct Answer: B

Upon study closure, investigators must maintain documentation that allows subject data to be linked back if necessary. The Subject Identification Code List is a key essential document for ensuring traceability while maintaining confidentiality.

ICH E6(R2) 8.3.21: ''Subject Identification Code List --- A list of all subjects randomized to trial numbers, allowing investigator to identify each subject in case follow-up is required. This list should be kept in a confidential manner and retained for the maximum retention period.''

ICH E6(R2) 8.4: Essential documents for investigators include items needed for subject identification, protocol compliance, and trial closure.

Other listed documents (randomization list, monitoring report, audit certificate) are maintained by the sponsor, not the investigator. The subject code list ensures that in the event of a safety issue, regulatory authority queries, or subject withdrawal, the investigator can trace back records.

Thus, the correct answer is B (Completed Subject Identification Code List).


ICH E6(R2), 8.3.21 (Essential documents: Subject identification code list).

ICH E6(R2), 8.4 (Essential documents for trial closure).

Question No. 5

In accordance with the ICH E2A Guideline, the sponsor must report an adverse event that is life-threatening, unexpected, and associated with the investigational drug to the regulatory authority as soon as possible but no later than how many calendar days after first knowledge of the event?

Show Answer Hide Answer
Correct Answer: B

Serious adverse events are subject to expedited reporting requirements.

ICH E2A 3.2.2: ''Fatal or life-threatening unexpected ADRs should be reported as soon as possible but no later than 7 calendar days after first knowledge.''

ICH E2A 3.2.3: Other serious unexpected events must be reported within 15 days.

Thus, the 7-day rule applies to life-threatening and unexpected events (as in this case).

Correct answer: B (7 days).


ICH E2A, 3.2.2.

Unlock All Questions for SOCRA CCRP Exam

Full Exam Access, Actual Exam Questions, Validated Answers, Anytime Anywhere, No Download Limits, No Practice Limits

Get All 130 Questions & Answers